Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Development, Optimization, And Evaluation Of PEGylated Brucine-loaded PLGA Nanoparticles

Heba S Elsewedy, Bandar E Al Dhubiab, M. Mahdy, H. El-nahas
Published 2020 · Medicine, Chemistry

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Abstract The application of nanotechnology to drug delivery systems for cancer therapy has progressively received great attention. The most heavily investigated approach is the development of nanoparticles (NPs) utilizing biodegradable and biocompatible polymers such as poly (lactic-co-glycolic acid) (PLGA). These NPs could be further improved by surface modification utilizing a hydrophilic biodegradable polymer such as polyethylene glycol (PEG) to achieve passive targeting. Modified NPs can deliver drugs such as brucine (BRU), which has shown its potential in cancer therapy. The objective of the current investigation was to develop and evaluate the passive targeting of long-circulating PLGA NPs loaded with BRU. NPs were characterized in terms of drug-excipient compatibility studies, including FTIR and DSC; physicochemical evaluations including particle size, zeta potential, morphological evaluation, entrapment efficiency and percentage yield; total serum protein adsorbed onto NP surfaces; and in vitro release of the loaded drug. Factorial design was employed to attain optimal PLGA-loaded NPs. Finally, the in vivo anti-tumor activity of BRU-loaded PLGA NPs was evaluated in tumor-bearing mice. The NPs obtained had smooth surfaces with particle sizes ranged from 94 ± 3.05 to 253 ± 8.7 nm with slightly positive surface charge ranged from 1.09 ± 0.15 to 3.71 ± 0.44 mV. Entrapment of BRU ranged between 37.5 ± 1.8% and 77 ± 1.3% with yields not less than 70.8%. Total protein adsorbed was less than 25.5 µg total protein/1 mg NP. In vitro drug release was less than 99.1% at 168 h. Finally, significant reductions in tumor growth rate and mortality rate were observed for PEG PLGA NP formulations compared to both BRU solution and naked NPs.
This paper references
10.1186/s12935-018-0613-0
Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo
B. Yuan (2018)
10.1016/J.NANO.2005.12.003
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.
C. Reis (2006)
10.1016/J.JCONREL.2004.12.018
Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
E. Lee (2005)
10.1007/s11095-019-2620-9
Synthesis and Statistical Optimization of Poly (Lactic-Co-Glycolic Acid) Nanoparticles Encapsulating GLP1 Analog Designed for Oral Delivery
R. Ismail (2019)
10.3390/medicina55060294
Preparation, Optimization, and In Vivo Evaluation of Nanoparticle-Based Formulation for Pulmonary Delivery of Anticancer Drug
Nazimuddin Chishti (2019)
10.1016/J.CCLET.2018.02.015
One-pot photoreduction to prepare NIR-absorbing plasmonic gold nanoparticles tethered by amphiphilic polypeptide copolymer for synergistic photothermal-chemotherapy
Siqi Yang (2019)
10.3390/pharmaceutics11110609
Preparation and Evaluation of Atorvastatin-Loaded Nanoemulgel on Wound-Healing Efficacy
M. Morsy (2019)
10.1039/c7bm01206c
A multifunctional nanoplatform for cancer chemo-photothermal synergistic therapy and overcoming multidrug resistance.
Yunmei Peng (2018)
10.3390/ijerph16071260
The Influence of Ionic and Nonionic Surfactants on the Colloidal Stability and Removal of CuO Nanoparticles from Water by Chemical Coagulation
Rizwan Khan (2019)
Gold nanoparticles decorated with octreotide for somatostatin receptors targeting
A Ahmed (2015)
10.1016/j.ejpb.2012.11.030
Adsorption of plasma proteins on uncoated PLGA nanoparticles.
Karim Sempf (2013)
Preparation and characterization of nanoparticles containing ketoprofen and acrylic polymers prepared by emulsion solvent evaporation method
L Hoa (2012)
10.1208/s12249-013-9943-3
Chitosan-Modified PLGA Nanoparticles with Versatile Surface for Improved Drug Delivery
Y. Wang (2013)
Chitosan-modified PLGA nanopar
L Puwang (2013)
emulsion-solvent diffusion method
Y Mingjiang (2018)
10.1016/J.PROGPOLYMSCI.2011.01.001
Polymer nanoparticles: Preparation techniques and size-control parameters
J. D. Rao (2011)
10.1248/cpb.c16-00415
Evaluating the Properties of Poly(lactic-co-glycolic acid) Nanoparticle Formulations Encapsulating a Hydrophobic Drug by Using the Quality by Design Approach.
M. Kozaki (2017)
10.2147/IJN.S27226
Anti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma
J. Qin (2012)
10.1016/j.ijpharm.2016.08.058
In-vivo disposition characteristics of PEG niosome and its interaction with serum proteins.
Tamer M Shehata (2016)
One-pot photoreduction to prepare
Y Siqi (2019)
10.3390/pharmaceutics11050230
Nanoemulsion Based Vehicle for Effective Ocular Delivery of Moxifloxacin Using Experimental Design and Pharmacokinetic Study in Rabbits
Jigar Shah (2019)
10.1016/J.POWTEC.2012.11.003
Surface modification and paclitaxel drug delivery of folic acid modified polyethylene glycol functionalized hydroxyapatite nanoparticles
G. Venkatasubbu (2013)
10.1590/S1516-93322006000400007
Thermoanalytical study of praziquantel-loaded PLGA nanoparticles
R. Mainardes (2006)
10.2147/IJN.S136378
In vitro and in vivo evaluation of novel NGR-modified liposomes containing brucine
S. Li (2017)
10.1016/j.jconrel.2012.07.003
PEG-PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin.
Brijeshkumar Patel (2012)
10.1007/s11095-018-2548-5
Different Efflux Transporter Affinity and Metabolism of 99mTc-2-Methoxyisobutylisonitrile and 99mTc-Tetrofosmin for Multidrug Resistance Monitoring in Cancer
M. Kobayashi (2018)
10.3390/pharmaceutics10020057
Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
M. Danaei (2018)
10.1155/2014/191535
Characterisation of Drosophila Ubx CPTI000601 and hth CPTI000378 Protein Trap Lines
S. W. Choo (2014)
10.1111/jphp.13098
An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites
Mohamed F Attia (2019)
10.2788/98686
Considerations on a Definition of Nanomaterial for Regulatory Purposes
L. Goeran (2010)
10.3390/ijerph16224498
Perceived Accessibility, Satisfaction with Daily Travel, and Life Satisfaction among the Elderly
Katrin Lättman (2019)
10.2147/IJN.S24547
Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid
Chang-Gu Keum (2011)
Development and optimization of quercetin loaded PLGA nanoparticles by experimental design. Clujul Medical 88:214–23
R Lucia (2015)
10.1016/j.ejpb.2008.01.013
Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency.
Xiangrong Song (2008)
10.1016/J.JCONREL.2006.12.012
Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain.
J. Kreuter (2007)
10.15386/cjmed-418
Development and optimization of quercetin-loaded PLGA nanoparticles by experimental design
L. Tefas (2015)
10.3390/ijms151223909
PLGA Biodegradable Nanoparticles Containing Perphenazine or Chlorpromazine Hydrochloride: Effect of Formulation and Release
Mohammed Halayqa (2014)
10.3109/10837450.2014.908302
Development of polymeric nanoparticles with highly entrapped herbal hydrophilic drug using nanoprecipitation technique: an approach of quality by design
P. R. Vuddanda (2015)
10.1517/17425247.4.6.621
Advances and challenges of nanotechnology-based drug delivery systems
W. Jiang (2007)
10.1080/10717544.2017.1384862
In vitro and in vivo antitumor effect of gefitinib nanoparticles on human lung cancer
X. Ni (2017)
10.1016/j.ejpb.2008.09.011
In vivo investigation of tolerance and antitumor activity of cisplatin-loaded PLGA-mPEG nanoparticles.
G. Mattheolabakis (2009)
10.1080/17458080.2010.515247
Preparation and characterisation of nanoparticles containing ketoprofen and acrylic polymers prepared by emulsion solvent evaporation method
L. M. Hoa (2012)
Cationic formulation of paclitaxel - loaded poly D , L - lactic - co - glycolic acid ( PLGA ) nanoparticles using an emulsion - solvent diffusion method
R Yang (2009)
In vitro and in vivo antitumor
LN PharmSciTech 14585–92. Xiao (2017)
Nanoparticle: an overview
J Utpal (2011)
10.2147/IJN.S144545
Development of surface-engineered PLGA nanoparticulate-delivery system of Tet1-conjugated nattokinase enzyme for inhibition of Aβ40 plaques in Alzheimer’s disease
P. Bhatt (2017)
10.1016/J.AJPS.2015.09.004
Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: A co-surfactant study
N. Sharma (2016)
10.1016/S0168-3659(98)00116-3
PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.
T. Govender (1999)
10.1155/2014/560962
Development and Characterization of Nanoparticles for the Delivery of Gemcitabine Hydrochloride
Rekha Khaira (2014)
10.1002/PPSC.201400048
Docetaxel‐Loaded Nanoparticles of Dendritic Amphiphilic Block Copolymer H40‐PLA‐b‐TPGS for Cancer Treatment
Xiaowei Zeng (2015)
10.1016/j.ijpharm.2008.03.025
Determinants for in vivo anti-tumor effects of PEG liposomal doxorubicin: importance of vascular permeability within tumors.
K. Ogawara (2008)
10.1016/J.BIOMATERIALS.2003.08.069
Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
M. Ravi Kumar (2004)
Preparation and characterization of poly-epsilon-caprolactone nanoparticles containing griseofulvin.
Z. Zili (2005)
10.2147/IJN.S121881
Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile
Pedram Rafiei (2017)
10.2147/IJN.S50721
Hyaluronic acid-coated bovine serum albumin nanoparticles loaded with brucine as selective nanovectors for intra-articular injection
Z. Chen (2013)
Cytotoxic and anti-inflammatory activity of aqueous extract of Strychnosnux-vomica
A Gupta (2015)
10.22037/IJPR.2013.1362
Anticancer Activity of Nanoparticles Based on PLGA and its Co-polymer: In-vitro Evaluation
I. Amjadi (2013)
10.1016/J.IJPHARM.2005.01.020
Preparation and characterization of poly-?-caprolactone nanoparticles containing griseofulvin
Z. Zhang (2005)
10.1016/J.IJPHARM.2006.11.061
Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
A. Budhian (2007)
10.2147/IJN.S152474
Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex® nanoparticles for docetaxel delivery in ovarian cancer
Erfaneh Ghassami (2018)
Cationic formulation of paclitaxel
X Han (2009)
10.2147/NSA.S32837
Polymeric nanoparticles loaded with the 3,5,3'-triiodothyroacetic acid (Triac), a thyroid hormone: factorial design, characterization, and release kinetics.
Karen C Dos Santos (2012)
10.4172/2157-7439.1000149
Critical Process Parameters Evaluation of Modified Nanoprecipitation Method on Lomustine Nanoparticles and Cytostatic Activity Study on L132 Human Cancer Cell Line
A. Mehrotra (2012)
Nanoparticle: An overview of preparation and characterization
S. Pal (2011)
10.1016/j.ijpharm.2008.04.004
Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers.
Tamer M Shehata (2008)
Dual agents loaded PLGA nanopar
X Chin Chem Lett 30187–91. Song (2008)
10.1016/J.PORGCOAT.2007.06.006
The use of natural essential oils as antimicrobial solutions in paper packaging. Part II
A. Rodríguez (2007)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar